Tech Company Financing Transactions
Adapsyn Bioscience Funding Round
Genesys Capital and Pfizer Venture Investments participated in a funding round for Adapsyn Bioscience. The funding round was recorded on 1/10/2018.
Transaction Overview
Company Name
Announced On
1/10/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Genesys Capital (Kelly Holman)
Pfizer Venture Investments (Edmund Graziani)
Proceeds Purpose
The financing will support the company's internal drug development programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
175 Longwood Rd. South 104
Hamilton ON, L8P 0A1
Canada
Hamilton ON, L8P 0A1
Canada
Phone
Undisclosed
Website
Email Address
Overview
Adapsyn disrupts how we mine the microbes in and around us to discover new medicines. Adapsyn applies proprietary algorithms and artificial intelligence to genomic and metabolomic data from microbes to find novel natural product drug candidates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Andrew Haigh
Founder
Nathan Magarvey
VP - Bus. Development
Lloyd Mackenzie
Browse more venture capital transactions:
Prev: 1/10/2018: FoodMaven venture capital transaction
Next: 1/10/2018: Sagoon venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs